Acro Biomedical (ACBM) Liabilities and Shareholders Equity (2015 - 2025)
Acro Biomedical's quarterly Liabilities and Shareholders Equity came in at $14098.0 in Q4 2025, down 55.91% year-on-year from $31974.0 in Q4 2024, and up 226.12% quarter-over-quarter from $4323.0 in Q3 2025.
Acro Biomedical has reported Liabilities and Shareholders Equity for 11 years, with the latest figure at $14098.0 in Q4 2025.
- For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 55.91% year-over-year to $14098.0; the trailing twelve-month figure through Dec 2025 stood at $96873.0 (down 41.9% YoY), and the FY2025 full-year result was $14098.0, down 55.91% from the prior year.
- Liabilities and Shareholders Equity for Q4 2025 stood at $14098.0, up from $4323.0 in the prior quarter.
- The five-year high for Liabilities and Shareholders Equity was $938874.0 in Q1 2021, with the low at $4323.0 in Q3 2025.
- Average Liabilities and Shareholders Equity over 5 years is $364818.5, with a median of $298803.5 recorded in 2023.
- Year-over-year, Liabilities and Shareholders Equity sank 97.04% in 2023 and jumped 103.27% in 2024.
- Tracing ACBM's Liabilities and Shareholders Equity over 5 years: stood at $761077.0 in 2021, then dropped by 9.67% to $687486.0 in 2022, then sank by 91.5% to $58459.0 in 2023, then slumped by 45.31% to $31974.0 in 2024, then slumped by 55.91% to $14098.0 in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $14098.0 (Q4 2025), $4323.0 (Q3 2025), and $53277.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 474.42 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 311.76 Mn |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | 310.95 Mn |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 310.55 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 366.18 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | 289.04 Mn |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 272.82 Mn |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 286.39 Mn |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 262.39 Mn |
| 10 | Acro Biomedical | - | - | - | 14,098.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14,098.00 |
| Sep 30, 2025 | 4,323.00 |
| Jun 30, 2025 | 53,277.00 |
| Mar 31, 2025 | 25,175.00 |
| Dec 31, 2024 | 31,974.00 |
| Sep 30, 2024 | 38,676.00 |
| Jun 30, 2024 | 45,281.00 |
| Mar 31, 2024 | 50,792.00 |
| Dec 31, 2023 | 58,459.00 |
| Sep 30, 2023 | 19,027.00 |
| Jun 30, 2023 | 539,148.00 |
| Mar 31, 2023 | 656,937.00 |
| Dec 31, 2022 | 687,486.00 |
| Sep 30, 2022 | 643,648.00 |
| Jun 30, 2022 | 669,331.00 |
| Mar 31, 2022 | 728,594.00 |
| Dec 31, 2021 | 761,077.00 |
| Sep 30, 2021 | 629,828.00 |
| Jun 30, 2021 | 700,365.00 |
| Mar 31, 2021 | 938,874.00 |
| Dec 30, 2020 | 998,053.00 |
| Sep 30, 2020 | 989,107.00 |
| Jun 30, 2020 | 998,293.00 |
| Mar 31, 2020 | 1.02 Mn |
| Dec 31, 2019 | 932,126.00 |
| Sep 30, 2019 | 1.07 Mn |
| Jun 30, 2019 | 1.08 Mn |
| Mar 31, 2019 | 1.14 Mn |
| Dec 31, 2018 | 1.27 Mn |
| Sep 30, 2018 | 1.48 Mn |
| Jun 30, 2018 | 1.01 Mn |
| Mar 31, 2018 | 867,923.00 |
| Dec 31, 2017 | 764,534.00 |
| Sep 30, 2017 | 548,310.00 |
| Jun 30, 2017 | 2,500.00 |
| Mar 31, 2017 | 2,000.00 |
| Dec 31, 2016 | 2,391.00 |
| Sep 30, 2016 | 2,533.00 |
| Jun 30, 2016 | 2,341.00 |
| Mar 31, 2016 | 11,742.00 |
| Sep 30, 2015 | 29,460.00 |